Label - Pegfilgrastim, ( Neulasta), Amgen Incorporated - Amgen - Document - PDFSEARCH.IO

First Page		Document Content
Growth factors Oncology Pegfilgrastim Hematology Cytokines Granulocyte colony-stimulating factor Filgrastim Neutropenia Polyethylene glycol Medicine Biology Amgen		Label - Pegfilgrastim, ( Neulasta), Amgen Incorporated Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 49,95 KB Share Document on Facebook

	Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20 DocID: 1q6vz - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use tbo-filgrastim safely and effectively. See full prescribing information for tbo-filgrastim. tbo-filgrastim Injection DocID: 159jc - View Document
	GRANIX (tbo-filgrastim) injection LABEL DocID: 13IXZ - View Document
	If any part of your blood count is low the chemotherapy dose may be adjusted or you may be given a medicine called pegfilgrastim (Neulasta®) on the day after chemotherapy to support your blood count. Sometimes antibioti DocID: 11jLz - View Document
	Peptides & proteins PEG-ging peptides Gary Hu of American Peptide Company reviews the progress of PEGylation technology P DocID: ZJ64 - View Document